NDC 54973-5224-01 - KALI MURIATICUM
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54973-5224
- Requested NDC
- 54973-5224-01
- Package NDCs from labels
- 54973-5224-1, 54973-5224-2, 54973-5224-01
- Manufacturer
- Hyland's Inc.
- Effective date
- 2022-12-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| #5 Kali Mur. 6X 500 Tablets | Hyland's Inc. | 2022-12-19 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54973-5224-1 | KALI MURIATICUM | 500 in 1 BOTTLE, PLASTIC | TABLET | 500 | 4 | |
| 54973-5224-2 | KALI MURIATICUM | 1000 in 1 BOTTLE, PLASTIC | TABLET | 1000 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54973-5224 | KALI MURIATICUM (POTASSIUM CHLORIDE) TABLET [HYLAND'S INC.] | 4 | Current NDC, Legacy NDC, 2 package rows | 20221220_2e8a4762-d28d-4b64-892f-913e04d18d2d.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| POTASSIUM CHLORIDE | ACTIVE INGREDIENT | 660YQ98I10 | KALI MURIATICUM (POTASSIUM CHLORIDE) TABLET [HYLAND'S] | 1 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | KALI MURIATICUM (POTASSIUM CHLORIDE) TABLET [HYLAND'S] | 1 | |
| ACACIA | INACTIVE INGREDIENT | 5C5403N26O | KALI MURIATICUM (POTASSIUM CHLORIDE) TABLET [HYLAND'S] | 1 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | KALI MURIATICUM (POTASSIUM CHLORIDE) TABLET [HYLAND'S] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Major Pharmaceuticals | 33ad1eb2-1f05-461c-b01d-82dee4231556 | 2026-02-11 | Warnings, Adverse reactions | 660YQ98I10 |
| DPT-TOX | DROSERA, ECHINACEA, HYPERICUM, KALI MUR, MEZEREUM, SILICEA, THUJA | Nutrition Center Inc dba Nutri-West dba Micro-West | 5e39f4e6-939f-4b71-9cc5-6d4b8711ea32 | 2026-02-04 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Major Pharmaceuticals | 5c2e888c-2f1e-4d5a-a456-20774ca83302 | 2026-02-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Major Pharmaceuticals | 7d74652b-3513-4ebb-8b47-10b3603d04a7 | 2026-02-04 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | Rising Pharma Holdings, Inc. | 947c11ca-ca0c-42df-8cc5-3db06458ca5b | 2026-02-01 | Warnings, Adverse reactions | 660YQ98I10 |
| SUTAB | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | c020e973-dccf-4862-999e-17db6209a48a | 2026-01-31 | Warnings, Adverse reactions | 660YQ98I10 |
| POKONZA potassium chloride | POTASSIUM CHLORIDE | Carwin Pharmaceutical Associates, LLC | 2d938cbf-27aa-4f9c-a582-5564d3b72465 | 2026-01-22 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | AvKARE | 755a4a08-04ff-d7d1-a6fc-b8aeff3ae2c6 | 2026-01-15 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Advagen Pharma Limited | d528c0c1-b81f-4f7a-8518-e6911b23c3eb | 2026-01-13 | Warnings, Adverse reactions | 660YQ98I10 |
| Lung Drainage | ANTIMONIUM ARSENICICUM, BRYONIA (ALBA), CAMPHORA, CARBO VEGETABILIS, CHELIDONIUM MAJUS, CHININUM MURIATICUM, CUPRUM METALLICUM, GELSEMIUM SEMPERVIRENS, HAEMOPHILUS INFLUENZAE B, IPECACUANHA, KALI MURIATICUM, LOBELIA PURPURESCENS, LUNG (SUIS), MYCOPLASMA PNEUMONIAE, MYCOPLASMA PNEUMONIAE DNA, OXYGENIUM, PHOSPHORUS, PNEUMOCOCCINUM, SENEGA OFFICINALIS, STANNUM METALLICUM, VERATRUM VIRIDE | Deseret Biologicals, Inc. | fd109172-46c3-444e-9fa0-124f785c3fb5 | 2026-01-09 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | AvPAK | f32df7c0-33eb-e6d6-e053-2a95a90a2e8d | 2026-01-09 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Baxter Healthcare Corporation | 092ddee4-572d-4771-8d95-880cea01097e | 2026-01-09 | Warnings, Adverse reactions | 660YQ98I10 |
| Southeast Regional 1024 | SOUTHEAST REGIONAL | Professional Complementary Health Formulas | 7a4ff3cf-6897-4cca-b907-556270642e04 | 2026-01-08 | Warnings | 5C5403N26O |
| Trees 2 1017 | TREES 2 | Professional Complementary Health Formulas | 601c8ffe-35c2-4dcc-a503-7d9b9998e284 | 2026-01-08 | Warnings | 5C5403N26O |
| Flex Drops 2024 | FLEX DROPS | Professional Complementary Health Formulas | e857670f-de84-494e-9e81-80144792d1fa | 2026-01-08 | Warnings | 660YQ98I10 |
| Cell Salt Combination 8013 | CELL SALT COMBINATION | Professional Complementary Health Formulas | b3a33345-3c3d-4f86-ae4d-757c65fd1ed3 | 2026-01-08 | Warnings | 660YQ98I10 |
| Lyme Nosode Drops 2128 | LYME NOSODE DROPS | Professional Complementary Health Formulas | c9fed770-938a-406b-ac95-593d1318ecce | 2026-01-08 | Warnings | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Advagen Pharma Limited | a9e9d134-55d0-47ae-925f-de07e7ffa4b8 | 2026-01-07 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Advagen Pharma Ltd. | f4497c26-da16-45b0-975d-81f2c2132704 | 2026-01-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23b10bd6-11bc-495e-bb05-ec332a9b3f21 | 2026-01-06 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.